Increased 3-nitrotyrosine levels in mitochondrial membranes and impaired respiratory chain activity in brain regions of adult female rats submitted to daily vitamin A supplementation for 2 months  by de Oliveira, Marcos Roberto et al.
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Vitamin  A  supplementation  among  women  is  a  common  habit  worldwide  in  an attempt  to  slow aging  pro-
gression due  to the  antioxidant  potential  attributed  to retinoids.  Nonetheless,  vitamin  A elicits  a myriad  of
side  effects  that  result  from  either  therapeutic  or  inadvertent  intake  at varying  doses  for  different  periods.
The  mechanism  behind  such  effects  remains  to be  elucidated.  In this  regard,  we performed  the  present
work aiming  to  investigate  the  effects  of  vitamin  A  supplementation  at  100,  200,  or 500  IU/kg  day−1
for  2 months  on female  rat  brain,  analyzing  tissue  lipid  peroxidation  levels,  antioxidant  enzyme  activ-
ities  (both  Cu/Zn–superoxide  dismutase  –  SOD  –  and  Mn–SOD);  glutathione  S-transferase  (GST)  and
monoamine  oxidase  (MAO)  enzyme  activity;  mitochondrial  respiratory  chain  activity  and  redox  param-
eters in mitochondrial  membranes,  as  well  as  quantifying  - and  -synucleins,  -amyloid  peptide1–40,
immunoglobulin  heavy-chain  binding  protein/78  kDa  glucose-regulated  protein  (BiP/GRP78),  receptor
for  advanced  glycation  end  products  (RAGE),  D2  receptor,  and  tumor  necrosis  factor- (TNF-)  contents
in  rat  frontal  cortex,  hippocampus,  striatum,  and  cerebellum.  We  observed  increased  lipid peroxidation
marker  levels,  altered  Cu/Zn–SOD  and  Mn–SOD  enzyme  activities,  mitochondrial  nitrosative  stress,  and
impaired  respiratory  chain  activity  in  such  brain  regions.  On  the  other  hand,  we  did not ﬁnd any  change
in  MAO  and  GST  enzyme  activities,  and  on  - and  -synucleins,  -amyloid  peptide1–40, GRP78/BiP,  RAGE,
D2  receptor,  and  TNF-  contents.  Importantly,  we  did  not  observed  any  evidence  regarding  an  antioxi-
dant  effect  of  such  vitamin  at low  doses  in  this  experimental  model.  The  use  of  vitamin  A  as  an  antioxidant
eeds  therapy  among  women  n
. Introduction
The recent studies demonstrating increased mortality rates
mong vitamin A supplements users caused concern among public
ealth researchers [3,4]. The purpose of vitamin A use is that this
itamin exerts an antioxidant role at low doses [29]. However, it
as been demonstrated that vitamin A is not only an antioxidant
gent: vitamin A is a redox-active molecule (as well as its deriva-
ives, the retinoids), i.e. it would interfere in the redox environment
epending on its concentration and on some other conditions, as for
nstance the state of cellular antioxidant defenses (both enzymatic
nd non-enzymatic) and the quality of mitochondrial function [18].
Although the recommendations to avoid excessive vitamin A
ntake are widely reported, it is not observed the efﬁcacy of
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such action on both developed and developing countries, since in
addition to vitamin supplements, subjects have ingested vitamin
A-fortiﬁed foods without paying attention to possible excess as
consequence of such habit [1,26].  Apart from increased mortality
rates among vitamin A users, it was published increased risk of bone
fracture and hepatotoxicity among women utilizing daily vitamin A
supplementation at low doses (≤25,000 IU/day, i.e. near 420 IU/kg
to a woman weighing 60 kg) (see [1] for a review). Furthermore,
cognitive disturbances were described as consequence of perma-
nent vitamin A consumption [26,28]. Then, daily vitamin A intake
as a supplementation may  decrease signiﬁcantly life quality when
the levels of such vitamin may  be achieved through normal diet;
however, the mechanisms by which such effects are mediated are
not completely understood.
We have demonstrated that vitamin A treatment at clinical
Open access under the Elsevier OA license.doses (1000–9000 IU/kg day−1) exerted a pro-oxidant effect on
some male rat brain regions. Additionally, we  reported mitochon-
drial impairment regarding respiratory chain function in rat brain
and liver [6–12]. Recently, our research group has found increased
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mounts of -synuclein in rat substantia nigra and striatum [10],
uggesting that, at least in part, vitamin A at the doses tested in that
ork may  be deleterious when applied in patients suffering from
ental diseases as Parkinson’s disease, for example, which affect
uch brain area. However, there is a lack of data in the literature
eporting the effects of vitamin A supplementation at low doses on
emale rat brain homeostasis. Then, based on the fact that exists
oor information regarding the consequences of vitamin A sup-
lementation at low doses (which are commonly ingested daily as
ietary supplements) on female rat brain redox state, we  performed
he present study to investigate the effects of vitamin A at 100, 200,
nd 500 IU/kg day−1 for 2 months on rat frontal cortex, hippocam-
us, striatum, and cerebellum. Vitamin A supplementation for 2
onths is commonly recommended clinically to patients suffering
rom dermatological, immunological, and nutritional disturbances,
s reviewed [15]. It was not analyzed vitamin A supplementation
or acute periods in this work due to the absence of signiﬁcant
ffects previously obtained by our research group regarding female
ats and such low vitamin A doses (unpublished data). We  analyzed
ere the contents of -synuclein, -amyloid peptide1–40, dopamine
eceptor 2 (D2 receptor), GRP78/BiP protein (a marker of endoplas-
ic  reticulum stress), and mitochondrial electron transfer chain
nzyme activity in the brain of female rats exposed to two  months
f vitamin A supplementation.
. Material and methods
.1. Animals
Four-month-old (regular 4-day cyclic) adult female Wistar rats (260–290 g)
ere obtained from our own breeding colony. They were caged in groups of four
ith free access to food and water and were maintained on a 12-h light–dark cycle
7:00–19:00 h), at a temperature-controlled colony room (23 ± 1 ◦C). These con-
itions were maintained constant throughout the experiments. All experimental
rocedures were performed in accordance with the National Institute of Health
uide for the Care and Use of Laboratory Animals (NIH publication number 80-23
evised 1996) and the Brazilian Society for Neuroscience and Behavior recommenda-
ions for animal care. Our research protocol was approved by the Ethical Committee
or animal experimentation of the Federal University of Rio Grande do Sul.
.2.  Drugs and reagents
Arovit® (retinol palmitate, a water-soluble form of vitamin A) was  purchased
rom Roche, Sao Paulo, SP, Brazil. Polyclonal antibody to 3-nitrotyrosine was
btained from Calbiochem, USA. Polyclonal antibodies to (- and (-synucleins and
2  receptor were purchased from Chemicon International, USA. GRP78/BiP poly-
lonal antibody was  obtained from Cell Signaling, USA. TNF-( assay kit was  obtained
rom  BD Biosciences, San Diego, CA, USA. All other chemicals were purchased from
igma, St. Louis, MO, USA. Vitamin A treatment was  prepared daily and it occurred
y  protecting from light.
.3. Estrous cycle phases determination
Vaginal smear cytology analyses were used for daily determination of estrous
ycle phases according to Marcondes et al. [24].
.4. Treatment
The animals were treated once a day for 2 months with a gavage. The treat-
ents were carried out at night (i.e. when the animals are more active and take a
reater amount of food) in order to ensure maximum vitamin A absorption, since
his vitamin is better absorbed during or after a meal. The animals received vehicle
0.15 M saline; N = 9), 100 (N = 8), 200 (N = 7 animals), or 500 (N = 7 animals) IU/kg of
etinol palmitate (vitamin A) orally via a metallic gastric tube (gavage) in a maximum
olume of 0.5 mL.  Adequate measures were taken to minimize pain or discomfort.
.5.  Oxidative stress and antioxidant enzyme activities analyses
Before sacriﬁce, the animals were anesthetized with ketamine plus xylazine
100 mg/kg and 14 mg/kg, respectively). The animals were sacriﬁced by decapita-
ion at 24 h after the last vitamin A administration. The frontal cortices, hippocampi,
triata, and cerebella were dissected out in ice immediately after the rats were sacri-
ced and stored at −80 ◦C for posterior oxidative stress analyses. The samples were
omogenized in phosphate-buffered saline (PBS; pH 7.4) and centrifuged (700 × g,
 min  at 4 ◦C) to remove cellular debris. Supernatants were used to all biochemicalh Bulletin 86 (2011) 246– 253 247
assays described here. All the results were normalized by the protein content using
bovine albumin as standard [21].
2.5.1. Thiobarbituric acid reactive species (TBARS)
As  an index of lipid peroxidation, we used the formation of TBARS during an
acid-heating reaction, which is widely adopted as a method for measurement of lipid
redox state, as previously described [13]. Brieﬂy, an aliquot of each sample (0.3 mL)
was  mixed with 0.6 mL of 10% trichloroacetic acid (TCA) and was centrifuged at
10,000 × g for 10 min at 4 ◦C. Supernatants were collected (0.5 mL)  and were mixed
with 0.5 mL  of 0.67% thiobarbituric acid (TBA), and then heated in a boiling water
bath  for 25 min. TBARS were determined by the absorbance at 532 nm.  We  have
obtained TBARS concentration in the samples from a calibration curve that was
performed using 1,1,3,3-tetramethoxypropane as standard, which was subjected to
the same treatment as that applied to the supernatants of the samples. Results are
expressed as nmol TBARS/mg protein.
2.5.2. Superoxide dismutases enzyme activities
Cytosolic superoxide dismutase (Cu/Zn–SOD) enzyme activity was assessed by
quantifying the inhibition of superoxide-dependent adrenaline auto-oxidation in
a  spectrophotometer at 480 nm, as previously described [25], and the results are
expressed as U SOD/mg protein. Mitochondrial SOD (Mn–SOD) enzyme activity
was  quantiﬁed in the presence of 2 mM KCN, which inhibits by 97–99% Cu/Zn–SOD
enzyme, as previously described [34].
2.6. Mitochondrial electron transfer chain (METC) activity
Mitochondria from fresh rat brain were isolated as described elsewhere [20].
Brieﬂy, frontal cortex, hippocampus, striatum, and cerebellum of Wistar rats were
suspended in ice-cold isolation buffer A (220 mM mannitol, 70 mM sucrose, 5 mM
HEPES (pH 7.4), 1 mM EGTA, and 0.5 mg/mL  fatty-acid free bovine serum albumin)
and were gently homogenized with a glass-homogenizer and centrifuged at 2000 × g
for  10 min  at 4 ◦C. Approximately three-quarters of the supernatant were further
centrifuged at 10,000 × g for 10 min at 4 ◦C in a new tube. The ﬂuffy layer of the
pellet was removed by gently shaking with buffer A and the ﬁrmly packed sediment
was  resuspended in the same buffer without EGTA and centrifuged at 10,000 × g
for  10 min  at 4 ◦C. The mitochondrial pellet was resuspended in buffer B (210 mM
mannitol, 70 mM sucrose, 10 mM HEPES–KOH (pH 7.4), 4.2 mM succinate, 0.5 mM
KH2PO4, and 4 (g/mL rotenone). This procedure, which was designed to isolate intact
mitochondria rather than to recover all of that present in the cerebral cortex, yielded
about 4–8 mg of mitochondrial protein/g of each rat brain region.
2.6.1. Complex I-CoQ-III activity
Complex I-CoQ-III activity was determined by following the increase in
absorbance due to reduction of cytochrome c at 550 nm with 580 nm as reference
wavelength (∈ = 19.1 mM−1 cm−1). The reaction buffer contained 20 mM potassium
phosphate, pH 8.0, 2.0 mM KCN, 10 (M EDTA, 50 (M cytochrome c, and 20–45 (g
supernatant protein. The reaction started by addition of 25 (M NADH and was mon-
itored at 30 ◦C for 3 min before the addition of 10 (M rotenone, after the which
the  activity was monitored for an additional 3 min. Complex I–III activity was the
rotenone-sensitive NADH:cytochrome c oxidoreductase activity [32].
2.6.2. Complex II and succinate dehydrogenase (SDH) activities
Complex II (succinate-DCPIP-oxidoreductase) activity was measured by follow-
ing  the decrease in absorbance due to the reduction of 2,6-dichloroindophenol
(DCPIP) at 600 nm with 700 nm as reference wavelength (∈ = 19.1 mM−1 cm−1). The
reaction mixture consisting of 40 mM potassium phosphate, pH 7.4, 16 mM succi-
nate and 8.0 (M DCPIP was preincubated with 48–80 (g supernatant protein at 30 ◦C
for 20 min. Subsequently, 4.0 mM sodium azide and 7.0 (M rotenone were added
and  the reaction was  started by addition of 40 (M DCPIP and was monitored for
5  min  at 30 ◦C. Succinate dehydrogenase (SDH) activity was assessed by adding
1  mM phenazine methasulphate to the reaction mixture. Then, SDH activity was
monitored for 5 min  at 30 ◦C at 600 nm with 700 nm as reference wavelength [14].
2.6.3. Complex II-CoQ-III activity
Complex II-CoQ-III activity was measured by following the increase in
absorbance due to the reduction of cytochrome c at 550 nm with 580 nm as the ref-
erence wavelength (∈ = 21 mM−1 cm−1). The reaction mixture consisting of 40 mM
potassium phosphate, pH 7.4, 16 mM succinate was preincubated with 50–100 (g
supernatant protein at 30 ◦C for 30 min. Subsequently, 4.0 mM sodium azide and
7.0 (M rotenone were added and the reaction started by the addition of 0.6 (g/mL
cytochrome c and monitored for 5 min at 30 ◦C [14].
2.6.4. Complex IV activity
Complex IV activity was measured by following the decrease in absorbance dueto  the oxidation of previously reduced cytochrome c at 550 nm with 580 nm as
reference wavelength (∈ = 19.15 mM−1 cm−1). The reaction buffer contained 10 mM
potassium phosphate, pH 7.0, 0.6 mM n-dodecyl-(-d-maltoside, 2–4 (g supernatant
protein and the reaction was started with addition of 0.7 (g reduced cytochrome c.
The activity of complex IV was measured at 25 ◦C for 10 min  [31].
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Fig. 1. The effects of vitamin A supplementation on lipid peroxidation levels (A),48 M.R. de Oliveira et al. / Brain R
.7.  Monoamine oxidase (MAO) enzyme activity
Brieﬂy, the oxidation of 0.06 mM kynuramine in PBS (pH 7.4) at 360 nm was
ecorded using a spectrophotometer at 37 ◦C, as previously described [37].
.8. Enzyme-linked immunosorbent assay (ELISA) to 3-nitrotyrosine, BiP, (- and
-synucleins, (-amyloid peptide (1–40), RAGE, and D2 receptor contents
Indirect ELISA assay was performed to analyze changes in the content of (-
myloid peptide (1–40) by utilizing a polyclonal rabbit antibody to (-amyloid
eptide (1–40) diluted 1:4000 in phosphate-buffered saline (PBS) pH 7.4 with 5%
lbumin. A standard curve with puriﬁed (-amyloid peptide (1–40) was  utilized in
rder to obtain a factor to calculate the amount of (-amyloid peptide (1–40) in rat
amples. The polyclonal rabbit antibodies to (- and (-synucleins were diluted 1:1000
n  PBS with 5% albumin. Dopamine D2R polyclonal antibody was  diluted 1:4000 in
BS with 5% albumin. RAGE polyclonal rabbit antibody was  diluted 1:2000 in PBS
ith 5% albumin. Polyclonal rabbit antibody to 3-nitrotyrosine was diluted 1:2000
n PBS with 5% albumin according to the manufacturer’s instructions. In mitochon-
rial membranes, 3-nitrotyrosine levels were quantiﬁed following mitochondrial
solation according to Poderoso et al. [30]. Polyclonal antibody to BiP was  diluted
:1000 in PBS with 5% albumin. Brieﬂy, microtiter plates (96-well ﬂat-bottom) were
oated for 24 h with the samples diluted 1:2 in PBS with 5% albumin. Plates were
hen  washed four times with wash buffer (PBS with 0.05% Tween-20), and the spe-
iﬁc  antibodies were added to each plate for 2 h at room temperature. After washing
four times), a second incubation with anti-rabbit antibody peroxidase conjugated
diluted 1:1000) for 1 h at room temperature was  carried out. After addition of sub-
trates (hydrogen peroxide and 3,3′ ,5,5′-tetramethylbenzidine 1:1, v/v), the samples
ere read at 450 nm in a plate spectrophotometer. Results are expressed as changes
n  percentage among the groups.
.9. Sandwich ELISA to TNF-( quantiﬁcation
We  have measured TNF- through commercial kit for enzyme-linked
mmunosorbent assay (ELISA) according manufacturer’s instructions (BD Bio-
ciences). Tissue samples were collected and suspended in lysis buffer containing
rotease inhibitors. Following cell lysis, the homogenate was  centrifuged, and a por-
ion of the supernatant was reserved for protein concentration measurement, and
he  remaining was stored at −80 ◦C for posterior TNF-( levels quantiﬁcation. The
amples were read in a microplate spectrophotometer at 450 nm.
.10. Glutathione-S-transferase (GST) activity
Glutathione-S-transferase (GST) activity was  determined spectrophotometri-
ally according to the method of Habig and colleagues [17]. GST activity was
uantiﬁed in female rat brain regions homogenates in a reaction mixture containing
 mM 1-chloro-2,4-dinitrobenzene (CDNB), and 1 mM glutathione as substrates in
.1  M sodium phosphate buffer, pH 6.5, at 37 ◦C. Enzyme activity was  calculated by
he  change in the absorbance value from the slope of the initial linear portion of the
bsorbance time curve at 340 nm for 5 min. Enzyme activity was expressed as nmol
f  CDNB conjugated with glutathione/min mg−1 protein.
.11. Statistical analyses
Biochemical data are expressed as means ± standard error of the mean (S.E.M.);
-values were considered signiﬁcant when p < 0.05. Differences in experimental
roups were determined by one-way ANOVA followed by the post hoc Tukey’s test
henever necessary.
. Results
.1. Oxidative damage and superoxide dismutases enzyme
ctivities
Vitamin A supplementation for 2 months did not alter lipid
eroxidation levels in female rat frontal cortex, striatum, and
erebellum. On the other hand, we observed increased lipid perox-
dation levels in the hippocampus of the female rats that received
itamin A supplementation at 500 IU/kg day−1 for 2 months
p < 0.05; Fig. 1A). Cytosolic superoxide dismutase (Cu/Zn–SOD)
nzyme activity was increased only in the frontal cortex and hip-
ocampus of the rats that were daily treated with vitamin A at
00 IU/kg day−1 (p < 0.05; Fig. 1B). Mitochondrial SOD (Mn–SOD)
nzyme activity did increase in the rat brain regions analyzed here
p < 0.05; Fig. 1C).Cu/Zn–SOD (B) and Mn–SOD (C) enzyme activities in adult female Wistar rats frontal
cortex, hippocampus, striatum, and cerebellum. Data are mean ± S.E.M. (n = 7–9 per
group). *p < 0.05 (one-way ANOVA followed by the post hoc Tukey’s test).
3.2. Mitochondrial electron transfer chain (METC) activity
As depicted in Fig. 2A, vitamin A supplementation at
500 IU/kg day−1 for 2 months increased complex I–III enzyme
activity in female rat brain regions (p < 0.05; Fig. 2A). Com-
plex II, succinate dehydrogenase (SDH), and complex II–III
enzyme activities did not change in this experimental model
(Figs. 2B and C and 3A). However, vitamin A supplementation
at 500 IU/kg day−1 decreased complex IV enzyme activity in rat
frontal cortex and hippocampus without affecting such mitochon-
drial complex in other cerebral regions (p < 0.05; Fig. 3B).
3.3. MAO enzyme activity
MAO  enzyme activity did not change in this experimental model
(Fig. 3C).
3.4. 3-Nitrotyrosine levels and BiP/GRP78 content
According to Fig. 4A, we may  observe increased 3-nitrotyrosine
contents in the frontal cortex, hippocampus, and striatum of the
rats that received vitamin A at 500 IU/kg day−1 for 2 months
(p < 0.05). Nitrosative stress was  not observed in rat cerebellum
here (Fig. 4A). Similarly, increased nitrosative stress in mitochon-
drial membranes obtained from frontal cortex, hippocampus, and
striatum was  observed in the rats that were treated with vitamin
M.R. de Oliveira et al. / Brain Research Bulletin 86 (2011) 246– 253 249
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Fig. 2. The effects of vitamin A supplementation on complex I–III (A), complex II (B),
and  succinate dehydrogenase (SDH) (C) enzyme activities in adult female Wistar
rats frontal cortex, hippocampus, striatum, and cerebellum. Data are mean ± S.E.M.
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Fig. 3. The effects of vitamin A supplementation on complex II–III (A), complex IV
(B),  and monoamine oxidase (C) enzyme activities in adult female Wistar rats frontaln  = 7–9 per group). *p < 0.05 (one-way ANOVA followed by the post hoc Tukey’s
est).
 at 500 IU/kg day−1 (p < 0.05; Fig. 4B). BiP protein content did not
hange in this experimental model (Fig. 4C).
.5. Glutathione S-transferase (GST) enzyme activity, receptor for
dvanced glycation end products (RAGE) content, and tumor
ecrosis factor-  ˛ (TNF-˛) levels
As demonstrated in Fig. 5, vitamin A supplementation did not
lter GST enzyme activity, RAGE content, or TNF- levels in this
rotocol.
.6. ˛- and ˇ-Synucleins and ˇ-amyloid peptide1–40 levels
Vitamin A supplementation did not change - and -synucleins
nd -amyloid peptide contents in the present work (Fig. 6).
.7. Dopamine receptor 2 (D2 receptor)
We did not observe any change regarding D2 receptor levels in
he herein presented work (Fig. 7).
. DiscussionIn the present work, we demonstrate, for the ﬁrst time, that vita-
in  A supplementation at low doses (100, 200, or 500 IU/kg day−1)
or 2 months induces redox disturbances in female rat brain regions.cortex, hippocampus, striatum, and cerebellum. Data are mean ± S.E.M. (n = 7–9 per
group). *p < 0.05 (one-way ANOVA followed by the post hoc Tukey’s test).
An adult woman  weighting 60 kg would ingest 6000, 12,000, or
30,000 IU/day, respectively, which are commonly found in dietary
supplements worldwide. We  did not observe an antioxidant effect
in vitamin A-treated rats at such doses, indicating an absence of
effect of this vitamin in preventing oxidative or nitrosative dam-
age in rat central nervous system (CNS). Importantly, we  did not
ﬁnd any change regarding food intake and body weight among the
groups (data not shown), suggesting that vitamin A did not induce
metabolic disturbances in this experimental model, which could
favor redox disturbances indirectly. Moreover, vitamin A supple-
mentation did not cause any alteration in female rat estrous cycle
phases, indicating that the effects seen here are not associated to
hormonal dysfunction.
Vitamin A is a redox-active molecule, since it is able to either
protect biological systems from pro-oxidant species or to impair
redox homeostasis depending on its concentration. The character-
ization of vitamin A as an antioxidant have lead some subjects to
consume such vitamin at varying doses inadvertently, in addition
to retinol esters that are added to fortiﬁed foods in an attempt to
prevent vitamin deﬁciency. However, vitamin A deﬁciency occurs
only when the individual is maintained without pre- or pro-vitamin
A derivatives for a long time, since the mammalian liver possesses
a large capability to store vitamin A in the form of esters, mainly
retinol palmitate [27].
In addition to the inadvertent use of vitamin A, this vita-
min  is applied in some therapeutic interventions at moderate to
250 M.R. de Oliveira et al. / Brain Research Bulletin 86 (2011) 246– 253
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Fig. 4. The effects of vitamin A supplementation on 3-nitrotyrosine in rat brain
regions (A) and 3-nitrotyrosine content in mitochondrial membranes (B), and BiP
protein content (C) in adult female Wistar rats frontal cortex, hippocampus, stria-
tum, and cerebellum. Data are mean ± S.E.M. (n = 7–9 per group). *p < 0.05 (one-way
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Fig. 5. The effects of vitamin A supplementation on glutathione S-transferase (GST)
during catecholamines and serotonin degradation in non-neuronalNOVA followed by the post hoc Tukey’s test).
igh doses (500–9000 IU/kg day−1). For example, during leukemia
reatment or weight gain therapy to preterm infants, patients at
ifferent ages receive daily retinol palmitate doses from 25,000
o 150,000 IU [1,22,26,35,36]. Some beneﬁcial effects have been
bserved, but there is a compilation of side effects associated to
itamin A intake at high doses, from gastrointestinal disturbances
o cognitive decline [1,26,28]. Additionally, some authors postulate
hat vitamin A is an alternative choice during immunodeﬁciency
herapy [19]. Nonetheless, it has been demonstrated that vitamin
 did not increase patient immunity in some works, as reviewed
y Allen and Haskell [1].  Then, the efﬁcacy of vitamin A therapeutic
ntervention should be evaluated.
Here, we have shown that daily vitamin A supplementation
or two months induced lipid peroxidation in female rat hip-
ocampus (Fig. 1A), and increased both mitochondrial and cytosolic
uperoxide dismutase enzyme activities (Mn- and Cu/Zn–SOD,
espectively; Fig. 1B and C, respectively) in rat brain regions, then
ndicating a possible increase in superoxide anion radical (O2−•)
roduction, since such free radical is the main positive allosteric
ffector of SOD enzymes [18]. Increased Mn–SOD enzyme activity
ay  reduce the mitochondrial levels of O2−(; however, an increase
n the amount of hydrogen peroxide (H2O2) produced in the mito-
hondria, as a consequence of altered Mn–SOD enzyme activity,
ay  lead to DNA damage and lipid peroxidation in mitochondrial
embranes, as previously reviewed [18].enzyme activity (A), RAGE content (B), and TNF- levels (C) in adult female Wistar
rats frontal cortex, hippocampus, striatum, and cerebellum. Data are mean ± S.E.M.
(n  = 7–9 per group).
The main site of O2−( production inside mammalian cells is the
mitochondrial respiratory chain (at complex I and complex III) [16].
Actually, we  have seen in the herein presented work increased com-
plex I–III, but decreased complex IV enzyme activity in female rat
brain regions (Figs. 2 and 3, respectively). In this situation, it is
postulated that partial reduction of O2 in complex IV may  lead to
increased O2−( production as a result of decreased electron ﬂux
to complex IV or decreased capability of such complex to reduce
completely O2 to water [18]. In this regard, it is very plausible to
ﬁnd increased Mn–SOD, as well as CU/Zn–SOD enzyme activities,
as discussed above.
Besides, we have observed increased both total tissue and
mitochondrial 3-nitrotirosine content in this work (Fig. 4A and
B, respectively), indicating increased peroxynitrite (ONOO−) pro-
duction in female rat brain under vitamin A supplementation.
ONOO− is originated from the reaction between O2−( and NO(,
and induces protein damage by interacting with tyrosine residues
in proteins [5,33].  Then, these results indicate that even with an
increased Mn–SOD enzyme activity, may occur an over the count
production of O2−( that may  favor nitrosative stress seen here in
mitochondrial membranes and in the total tissue (Fig. 4A and B).
Additionally, rat mitochondria may be viewed as an alternative
source of H2O2 in the brain of female rats under vitamin A supple-
mentation. MAO  enzyme activity, which is also a source of H2O2cells, did not change in the present work (Fig. 3C).
Even though vitamin A supplementation induced mitochondrial
nitrosative stress, we did not observe any change regarding endo-
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Fig. 6. The effects of vitamin A supplementation on the levels of - and -synucleins and -amyloid peptide (1–40) in adult female Wistar rats frontal cortex, hippocampus,
striatum, and cerebellum. Data are mean ± S.E.M. (n = 7–9 per group).
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lasmic reticulum stress, as examined through GRP78/BiP protein
evels, a marker of reticular insult [2,23].  Additionally, vitamin A
upplementation did not change glutathione S-transferase (GST)
nzyme activity, receptor for advanced glycation end products
RAGE), or tumor necrosis factor- (TNF-)  levels in this exper-
mental model (Fig. 5). Taken together, these data indicate that
itamin A is not producing apolar compounds at concentrations
hat would stimulate GST enzyme activity, since such enzyme
elongs to a superfamily responsible for detoxiﬁcation events by
tilizing reduced glutathione (GST) to excrete apolar molecules
which are potentially toxic to biological membranes and other
iological systems) from mammalian cells [17]. Accordingly, RAGE
ontent did not change, even though we have observed increased
evels of oxidative and nitrosative stress markers here. Also, - or -
ynucleins, or -amyloid peptide levels did not change in the brain
f female rats (Fig. 6). Importantly, we did not observe a protective
ffect of vitamin A regarding the levels of such proteins/peptide,
ince lower levels of -amyloid peptide, for example, would indi-
ate vitamin A as a potential neuroprotective agent. Dopamine
eceptor 2 (D2 receptor), whose expression is regulated, at least
n part, by retinoids, was not affected by oral vitamin A supple-
entation regarding its levels (Fig. 7).
Overall, we may  conclude that vitamin A supplementation to
emale rat is able to induce redox disturbances in some brain
egions and caused an impairment in mitochondrial membranes
as observed through the nitrosative stress marker 3-nitrotyrosine)
s well as a dysfunction in the respiratory chain activity, suggest-
ng that dietary vitamin A supplementation among female subjects
eeds to be reexamined.
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